Trial Outcomes & Findings for The Validity, Reliability and Interpretability of Thai-version of Chronic Urticaria Quality of Life Questionnaire (NCT NCT02285023)

NCT ID: NCT02285023

Last Updated: 2019-02-08

Results Overview

Cross-cultural validity is the degree to which the performance of the Thai CU-Q2oL items can adequately reflect the performance of the original CU-Q2oL items. Exploratory factor analysis was used to determine scales with proper item division of the Thai CU-Q2oL. Principal component analysis with varimax rotation was employed. An eigenvalue ≥ 1 was chosen as the criterion to retain domains. Each item was classified into the domain when loading with a domain loading ≥ 0.5.

Recruitment status

COMPLETED

Target enrollment

166 participants

Primary outcome timeframe

4 week

Results posted on

2019-02-08

Participant Flow

Patients diagnosed as chronic idiopathic urticaria were invited to participate in the study at the Allergy clinic in the Department of Dermatology, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Participant milestones

Participant milestones
Measure
CU-Q2oL
* Evaluation by the Urticaria Activity Score (UAS7) * Fill the DLQI and CU-Q2oL questionnaire CU-Q2oL: The patients will be explained how to complete the Urticaria Activity Score (UAS7) form for evaluating their severity of chronic urticaria symptoms at home. At the 2nd visit, collect the 1st UAS7 assessment. Assessment the severity of chronic urticaria symptoms. The patients fill the 1st DLQI and CU-Q2oL questionnaire and get the 2nd UAS7 form and two-week appointment to follow up. At the 3th visit, collect the 2nd UAS7 assessment. Assessment the severity of chronic urticaria symptoms. The patients fill the 2nd DLQI and CU-Q2oL questionnaire.
Overall Study
STARTED
166
Overall Study
COMPLETED
166
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

The Validity, Reliability and Interpretability of Thai-version of Chronic Urticaria Quality of Life Questionnaire

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Chronic Idiopathic Urticaria Patients
n=166 Participants
* Evaluation by the Urticaria Activity Score (UAS7) * Fill the DLQI and CU-Q2oL questionnaire CU-Q2oL: The patients diagnosed as chronic idiopathic urticaria will be explained how to complete the Urticaria Activity Score (UAS7) form for evaluating their severity of chronic urticaria symptoms at home. At the 2nd visit, collect the 1st UAS7 assessment. Assessment the severity of chronic urticaria symptoms. The patients fill the 1st DLQI and CU-Q2oL questionnaire and get the 2nd UAS7 form and two-week appointment to follow up. At the 3th visit, collect the 2nd UAS7 assessment. Assessment the severity of chronic urticaria symptoms. The patients fill the 2nd DLQI and CU-Q2oL questionnaire.
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
166 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
131 Participants
n=5 Participants
Sex: Female, Male
Male
35 Participants
n=5 Participants
Region of Enrollment
Thailand
166 participants
n=5 Participants
Urticaria Activity Score
8.8 units on a scale
STANDARD_DEVIATION 9.6 • n=5 Participants
Dermatology Life Quality Index
4.67 Score
STANDARD_DEVIATION 5.3 • n=5 Participants
CU-Q2OL
19.91 units on a scale
STANDARD_DEVIATION 15.9 • n=5 Participants
Education
166 participants
n=5 Participants

PRIMARY outcome

Timeframe: 4 week

Cross-cultural validity is the degree to which the performance of the Thai CU-Q2oL items can adequately reflect the performance of the original CU-Q2oL items. Exploratory factor analysis was used to determine scales with proper item division of the Thai CU-Q2oL. Principal component analysis with varimax rotation was employed. An eigenvalue ≥ 1 was chosen as the criterion to retain domains. Each item was classified into the domain when loading with a domain loading ≥ 0.5.

Outcome measures

Outcome measures
Measure
Extraction Sums of Square Loading (% of Variance)
n=166 Participants
% of Variance - This column contains the percent of total variance accounted for by each factor.
Rotation Sums of Squared Loading (% of Variance)
n=166 Participants
The "% of variance" column tells you how much of the total variability (in all of the variables together) can be accounted for by each of these summary scales or factors.
Cross-Cultural Validity of Thai-version CU-Q2oL
Domain I (item 7,8,11-14 of CUQoL)
43.71 Percentage
22.11 Percentage
Cross-Cultural Validity of Thai-version CU-Q2oL
Domain II( Item 1-6, 9-10, 17 of CUQoL)
9.41 Percentage
20.21 Percentage
Cross-Cultural Validity of Thai-version CU-Q2oL
Domain III (Item 15-16, 18-23 of CUQoL)
7.33 Percentage
18.13 Percentage

SECONDARY outcome

Timeframe: baseline

Population: Mean score of domain I, II, III of Thai CU-Q2oL were correlated to mean score domain I, II, III of Thai DLQI, respectively

\- The CU-Q2oL Questionnaire is a 23-item HRQoL questionnaire. It measures three dimensions (scales) of HRQoL: domain I (sleep, leisure, concentration), domain II (symptom, eating limits), and domain III (mental status, looks, impact on life activities) The scores of domain I of CUQ2oL range between 0 and 26. The scores of domain II of CUQ2oL range between 0 and 39.The scores of domain III of CUQ2oL between 0 and 35. The minimum possible score is 0 and the maximum possible score is 100 for total scale. -The DLQI scores range from 0-30. Domain I (leisure), Domain II (symptoms and feeling), and Domain III (daily activities, work, school, and personal relationships). Meaning of DLQI Scores: 0-1 = no effect, 2-5 = small effect, 6-10 = moderate effect, 11-20 = very large effect, 21-30 = extremely large effect. The higher the score, the more quality of life is impaired for both the CUQ2oL and the DLQI.

Outcome measures

Outcome measures
Measure
Extraction Sums of Square Loading (% of Variance)
n=166 Participants
% of Variance - This column contains the percent of total variance accounted for by each factor.
Rotation Sums of Squared Loading (% of Variance)
n=166 Participants
The "% of variance" column tells you how much of the total variability (in all of the variables together) can be accounted for by each of these summary scales or factors.
Mean Total Score and Domain of Thai CU-Q2oL Scores From the Thai Version to Investigate Reliability of Thai-Version CU-Q2oL
Domain I
23.19 units on a scale
Standard Deviation 21.7
1.86 units on a scale
Standard Deviation 1.4
Mean Total Score and Domain of Thai CU-Q2oL Scores From the Thai Version to Investigate Reliability of Thai-Version CU-Q2oL
Domain II
19.09 units on a scale
Standard Deviation 16.6
1.79 units on a scale
Standard Deviation 1.5
Mean Total Score and Domain of Thai CU-Q2oL Scores From the Thai Version to Investigate Reliability of Thai-Version CU-Q2oL
Domain III
18.37 units on a scale
Standard Deviation 17.5
1.85 units on a scale
Standard Deviation 2.5

SECONDARY outcome

Timeframe: baseline and 2 weeks

\- Investigate the smallest reduction in the Thai CU-Q2oL that patients recognized as a meaningful improvement.

Outcome measures

Outcome measures
Measure
Extraction Sums of Square Loading (% of Variance)
n=17 Participants
% of Variance - This column contains the percent of total variance accounted for by each factor.
Rotation Sums of Squared Loading (% of Variance)
n=54 Participants
The "% of variance" column tells you how much of the total variability (in all of the variables together) can be accounted for by each of these summary scales or factors.
Change in Thai CU-Q2oL Scores From Baseline for Responders and Non-Responders
7.3 score
Standard Deviation 9.4
28.4 score
Standard Deviation 15.3

SECONDARY outcome

Timeframe: baseline and 2 weeks

Population: Responder group

The receiver operating characteristic (ROC) analysis and area under the curve (AUC) are acceptable as the units of measure for assess the ability of a questionnaire to changes in patients' health-related quality of life (HRQoL) impairment over time that represents to responsiveness to change and minimal clinical important difference (MCID). The AUC of the ROC analysis of 1, 0.9, 0.8, 0.7 and 0.5 were considered perfect, excellent, good, fair, and no better than chance, respectively.

Outcome measures

Outcome measures
Measure
Extraction Sums of Square Loading (% of Variance)
n=17 Participants
% of Variance - This column contains the percent of total variance accounted for by each factor.
Rotation Sums of Squared Loading (% of Variance)
The "% of variance" column tells you how much of the total variability (in all of the variables together) can be accounted for by each of these summary scales or factors.
Area Under the Curve for Thai CUQ2oL Scores in the Responder Group
0.90 probability
Interval 0.84 to 0.97

Adverse Events

Chronic Idiopathic Urticaria

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Prof. Kanokvalai Kulthanan

Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University

Phone: (662)419-4333

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place